Journals / Van Tıp Dergisi / 2003 / Cilt: 10 - Sayı: 3

Risk factory for development of nephropathy in type-2 diabetes mellitus

Tip II diabetes mellitusta nefropati gelişiminde risk faktörleri

Pages
65–68
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we suggest that frequent evaluation of albumin in urine analysis should be performed in those diabetes patients with poor regulated glucose levels, with disease duration longer than 10 years and with older age.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hyperglicemia, hypertension and hyperlipidemia are well known risk factors for diabetic nephropathy.
📊
Key Findings & Data:We included 100 patients with type 2 diabetes mellitus in the study to evaluate the effects of age, disease duration, HbAIc levels and obesity in development of diabetic nephropathy.
💡
Conclusion & Impact:In conclusion, we suggest that frequent evaluation of albumin in urine analysis should be performed in those diabetes patients with poor regulated glucose levels, with disease duration longer than 10 years and with older age.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Risk faktörleri · Diabetik nefropati · Diabetes mellitus

Abstract

Hyperglicemia, hypertension and hyperlipidemia are well known risk factors for diabetic nephropathy. We aimed at searching other possible risk factors related to diabetic nephropathy. We included 100 patients with type 2 diabetes mellitus in the study to evaluate the effects of age, disease duration, HbAIc levels and obesity in development of diabetic nephropathy. Our results revealed that high HbAIc levels, diabetes duration and age of the patient were consituting risk factors for diabetic nephropathy. In conclusion, we suggest that frequent evaluation of albumin in urine analysis should be performed in those diabetes patients with poor regulated glucose levels, with disease duration longer than 10 years and with older age.

Özet

Diabetik nefropati gelişmesinde hiperglisemi, hipertansiyon, hiperlipidemi bilinen risk faktörleridir. Biz çalışmamızda tip 2 diabetik hastalarda diabetik nefropati gelişimi ile ilişkili diğer risk faktörlerini araştırmayı amaçladık. Bu amaçla randomize seçilen tip 2 diabetik 100 hastada yaş, diabet süresi, HbAIc düzeyi ve obezitenin diabetik nefropati gelişmesindeki etkisini değerlendirdik. Sonuçlarımızda yüksek HbAIc düzeyi, diabet süresi ve hasta yaşının diabetik nefropati gelişiminde risk faktörü olduğunu saptadık. Bu nedenle 55 yaş üzeri, 10 yıl üzerinde diabet anamnezi olan, kan şekeri regülasyonu bozuk hastalarda sık aralıklarla idrarda albumin bakılmasını öneriyoruz.

🔖

Cite This Article

NADİR, I., TOPCU, S., İÇAĞASIOĞLU, S., YILDIRIM, N. (2003). Risk factory for development of nephropathy in type-2 diabetes mellitus. Van Tıp Dergisi, Cilt: 10 - Sayı: 3, 65–68. https://ajindex.com/articles/334278

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Muggeo M. Accelerated complications in Type 2 diabetes melHtus: the need for greater awareness and detection. Diabet Med;15 suppi 4:60-2,1998
  2. United States Renai Data System. Incidence and prevelance of ESRD. Am J Kidney Dis;32(2)3S-49,1998
  3. Türk Nefroloji Derneği 200İ registry raporu. İstanbul 2002
  4. Krolewski As, Laffel LMB, Krolewsky M et a!. Glycosylated hemoglobin and risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N Engl J Med; 332:1251-1255,1995
  5. Eschwege E. Epidemiology of type 2 diabetes, prognosis, prevalence, risk factors, complications. Arch Mal Coeur Vaiss; 93:13-7,2000
  6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progressionof long term complications in IDDM. N Engl J Med;329:977-9S6,1993
  7. UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. The Lancet;352:S37-853,199S
  8. UKPDS Group. Tight blood pressure control and risk of macrovascuiar and microvascular complications in type 2 diabetes. BMJ;317:703-13,1998
  9. Viberti GC. Hill RD, Jarrett RJ. et al. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet;26(l):I430-2,19S2
  10. DeFronzo RA. Diabetic nephropalhy: Diagnostic and Therapeutic Approach.In Current Management of Diabetes Mellitus. DeFronzo RA (ed) Mosby Year Book;ppl34-144,1998
  11. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects: Islington diabetes survey Lancet;3(2):530-533,1988
  12. Ohno T, Kato N, Shimizu M et al. Effect of age on the development or progression of albuminuria without hypertension. Diabetes Res;22(3):115-21,1993
  13. Allison DB, Saunders SE. Obesity in North America: An overwiew. Med Clin North Am;84:305-32,2000
  14. Tozawa M, Isek K, Iseki C et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int; 62(3):956-62,2002.